St. Jude Medical ontvangt Europese goedkeuring voor eerste geïmplanteerd neurostimulatiebedrijf voor behandeling van chronische migraine

The St. Jude Medical Genesis(TM) neurostimulation system is the only fully implantable neurostimulation system that is approved in Europe for peripheral nerve stimulation (PNS) of the occipital nerves for the management of the pain and disability for patients diagnosed with intractable chronic migraine. PNS for intractable chronic migraine involves the delivery of mild electrical pulses to the occipital nerves that are located just beneath the skin at the back of the head. A small electrical lead or leads are placed under the skin and connected to the Genesis neurostimulator, a pacemaker-like device, which produces the pulses of stimulation. Illustration provided by St. Jude Medical, Inc. (Graphic: Business Wire)

  • The St. Jude Medical Genesis(TM) neurostimulation system is the only fully implantable neurostimulation system that is approved in Europe for peripheral nerve stimulation (PNS) of the occipital nerves for the management of the pain and disability for patients diagnosed with intractable chronic migraine. PNS for intractable chronic migraine involves the delivery of mild electrical pulses to the occipital nerves that are located just beneath the skin at the back of the head. A small electrical lead or leads are placed under the skin and connected to the Genesis neurostimulator, a pacemaker-like device, which produces the pulses of stimulation. Illustration provided by St. Jude Medical, Inc. (Graphic: Business Wire)

  • The St. Jude Medical Genesis(TM) neurostimulation system is the only fully implantable neurostimulation system that is approved in Europe for peripheral nerve stimulation (PNS) of the occipital nerves for the management of the pain and disability for patients diagnosed with intractable chronic migraine. PNS for intractable chronic migraine involves the delivery of mild electrical pulses to the occipital nerves that are located just beneath the skin at the back of the head. A small electrical lead or leads are placed under the skin and connected to the Genesis neurostimulator, a pacemaker-like device, which produces the pulses of stimulation. Animation provided by St. Jude Medical, Inc.

  • The St. Jude Medical Genesis(TM) neurostimulation system is the only fully implantable neurostimulation system that is approved in Europe for peripheral nerve stimulation (PNS) of the occipital nerves for the management of the pain and disability for patients diagnosed with intractable chronic migraine. PNS for intractable chronic migraine involves the delivery of mild electrical pulses to the occipital nerves that are located just beneath the skin at the back of the head. A small electrical lead or leads are placed under the skin and connected to the Genesis neurostimulator, a pacemaker-like device, which produces the pulses of stimulation. Photo provided by St. Jude Medical, Inc. (Photo: Business Wire)

ST. PAUL, Minn.--()--St. Jude Medical, Inc. (NYSE:STJ), internationaal leverancier van medische apparatuur, heeft de eerste en enige wettelijke goedkeuring ontvangen, die ooit in de sector is uitgereikt voor het gebruik van een geïmplanteerd neurostimulatieapparaat bij patiënten met onbehandelbare chronische migraine. Het bedrijf ontving de Europese CE-markering voor zijn Genesis neurostimulatiesysteem voor perifere zenuwstimulatie van de achterhoofdzenuwen ter bestrijding van onbehandelbare migraine. Dit type migraine wordt gedefinieerd als een hoofdpijn die minstens vier uur per dag duurt en zich 15 dagen per maand of vaker voordoet, een matige handicap veroorzaakt, en waartegen drie of meer andere preventieve medicijnen niet effectief zijn gebleken.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Zie voor illustraties en bijlagen de Multimedia Galerij:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6848720&lang=nl

Contacts

St. Jude Medical
J.C. Weigelt, 651-756-4347
Investor Relations
jweigelt@sjm.com
Denise Landry, 972-309-8085
Media Relations
dlandry@sjm.com

Contacts

St. Jude Medical
J.C. Weigelt, 651-756-4347
Investor Relations
jweigelt@sjm.com
Denise Landry, 972-309-8085
Media Relations
dlandry@sjm.com